Skip to main content Back to Top
Advertisement

5/17/2016

Milrinone Injection

Reason for the Shortage

    • Fresenius Kabi states the reason for the shortage was increased demand for the product.
    • Hospira had milrinone injection on shortage due to increased demand.
    • West-Ward states the shortage was due to manufacturing delays.

Available Products

    • Milrinone injection, Baxter, 0.2 mg/mL, 100 mL premixed bag, 10 count, NDC 00338-6010-48
    • Milrinone injection, Baxter, 0.2 mg/mL, 200 mL premixed bag, 10 count, NDC 00338-6011-37
    • Milrinone injection, Fresenius Kabi, 1 mg/mL, 10 mL vial, 10 count, NDC 63323-0617-10
    • Milrinone injection, Fresenius Kabi, 1 mg/mL, 20 mL vial, 10 count, NDC 63323-0617-20
    • Milrinone injection, Fresenius Kabi, 1 mg/mL, 50 mL vial, 1 count, NDC 63323-0617-50
    • Milrinone injection, Pfizer, 0.2 mg/mL, 100 mL premixed bag, 10 count, NDC 00409-2776-23
    • Milrinone injection, Pfizer, 0.2 mg/mL, 200 mL premixed bag, 10 count, NDC 00409-2776-02
    • Milrinone injection, Pfizer, 1 mg/mL, 10 mL vial, 10 count, NDC 00409-0212-01
    • Milrinone injection, Pfizer, 1 mg/mL, 20 mL vial, 10 count, NDC 00409-0212-02
    • Milrinone injection, Pfizer, 1 mg/mL, 50 mL vial, 1 count, NDC 00409-0212-03
    • Milrinone injection, West-Ward, 0.2 mg/mL, 100 mL premixed bag, 10 count, NDC 00143-9719-10
    • Milrinone injection, West-Ward, 0.2 mg/mL, 200 mL premixed bag, 10 count, NDC 00143-9718-10
    • Milrinone injection, West-Ward, 1 mg/mL, 10 mL vial, 10 count, NDC 00143-9710-10
    • Milrinone injection, West-Ward, 1 mg/mL, 20 mL vial, 10 count, NDC 00143-9709-10
    • Milrinone injection, West-Ward, 1 mg/mL, 50 mL vial, 1 count, NDC 00143-9708-01

Estimated Resupply Dates

    • All marketed presentations are available.

Updated

Updated May 17, 2016 by Michelle Wheeler, PharmD, Drug Information Specialist. Created March 7, 2011 by Jane Chandramouli, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins